Court Dismisses Case Demanding DEA to Move Expeditiously to License Cannabis Cultivators
NORML
OCTOBER 21, 2019
The agency in 2016 first announced its intent to license private entities to grow cannabis for FDA-approved clinical trials. The Court’s order permits petitioners to return to the Court of Appeals “in the event” that DEA engages in “significant delays” in the future.
Let's personalize your content